Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Receivables (2018 - 2019)

Historic Receivables for DiaMedica Therapeutics (DMAC) over the last 2 years, with Q3 2019 value amounting to $1.3 million.

  • DiaMedica Therapeutics' Receivables changed N/A to $1.3 million in Q3 2019 from the same period last year, while for Sep 2019 it was $1.3 million, marking a year-over-year change of. This contributed to the annual value of $1.4 million for FY2018, which is N/A changed from last year.
  • As of Q3 2019, DiaMedica Therapeutics' Receivables stood at $1.3 million.
  • DiaMedica Therapeutics' 5-year Receivables high stood at $2.1 million for Q2 2019, and its period low was $1.3 million during Q3 2019.